111 Capital Purchases Shares of 13,559 Option Care Health, Inc. (NASDAQ:OPCH)

111 Capital acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 13,559 shares of the company's stock, valued at approximately $315,000.

Several other large investors also recently made changes to their positions in the business. Barclays PLC increased its position in shares of Option Care Health by 180.1% in the 3rd quarter. Barclays PLC now owns 310,194 shares of the company's stock worth $9,708,000 after purchasing an additional 199,454 shares during the last quarter. Blue Trust Inc. grew its position in Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock worth $109,000 after purchasing an additional 681 shares during the last quarter. KBC Group NV lifted its stake in shares of Option Care Health by 46.4% in the 4th quarter. KBC Group NV now owns 7,337 shares of the company's stock worth $170,000 after acquiring an additional 2,324 shares during the period. Pacer Advisors Inc. lifted its stake in shares of Option Care Health by 2.2% in the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock worth $591,000 after acquiring an additional 537 shares during the period. Finally, Highland Capital Management LLC acquired a new stake in Option Care Health during the fourth quarter valued at approximately $238,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Option Care Health Trading Up 1.8%

Shares of OPCH stock traded up $0.57 during trading hours on Friday, hitting $32.83. 1,258,347 shares of the company were exchanged, compared to its average volume of 1,864,720. The company has a 50 day simple moving average of $32.73 and a two-hundred day simple moving average of $29.62. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a market cap of $5.38 billion, a P/E ratio of 27.59, a P/E/G ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. The company had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business's revenue for the quarter was up 16.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.26 EPS. Equities analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Barrington Research restated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research report on Wednesday, April 30th. JPMorgan Chase & Co. upped their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. Finally, JMP Securities reiterated a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.